Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.

This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.

This article applies principlism to what a “shoppable service” model would demand of clinicians in practice.

There are a few reasons why incentivizing clinicians to spend more time with patients can improve health outcomes.

Genevieve S. Silva joins Ethics Talk to discuss her article, coauthored with Dr Cassandra Thiel: “What Would It Mean for Health Care Organizations to Justly Manage Their Waste?”

Restructuring health care waste management involves making existing waste audit data transparent.

Dr Jing Li joins Ethics Talk to discuss her article, coauthored with Dr Robert Tyler Braun, Sophia Kakarala, and Dr Holly G. Prigerson: “How Should Cost-Informed Goals of Care Decisions Be Facilitated at Life’s End?”

Dr Mustfa K. Manzur joins Ethics Talk to discuss his article, coauthored with Drs Sharon Griswold and Wendy Dean: "What Should Clinicians Do When Health Services Are Improperly Billed in Their Names?"

Dr Christopher Whaley joins Ethics Talk to discuss his article, coauthored with Dr Austin Frakt: “If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important?”

Dr Kevin Schulman joins Ethics Talk to discuss his article, coauthored with Dr Barak Richman: “Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm.”